Medication info

Rubis Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›Strength being verifiedTripotassium Bismuth Dicitrate›Strength being verifiedSucralfate Hydrate›Strength being verified
Manufacturer / importer
Hankook Hyutex Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201403909 · Approved 2014.08.22

This product's status changed to Approval withdrawn on 2023.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers, gastritis, gastroesophageal reflux disease); prevention of Mendelson's syndrome
Who uses it
Adults
Adult dosage
Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and other conditions usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.

Ingredients

Manufacturer
Hankook Hyutex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers, gastritis, gastroesophageal reflux disease); prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAIDs
View approved original text

This medication is used for gastrointestinal diseases such as ulcers occurring in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia, and it helps treat ulcers that may occur after surgery. It is effective in preventing and treating ulcers in the stomach and duodenum caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It contributes to alleviating symptoms of various gastrointestinal diseases and restoring normal gastrointestinal function.

Dosage and Administration

Adult dosage

Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and other conditions usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.

Precautions

This medicine should not be used by patients with poor kidney function or undergoing dialysis. Additionally, it should not be administered to patients who have had allergic reactions to this medicine or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and newborns, and patients who need to restrict potassium intake. Patients with liver function problems or a history of drug allergic reactions, elderly patients, those with a history of kidney disorders, and patients taking non-steroidal anti-inflammatory drugs should be observed carefully when using this medicine. Especially since it can mask symptoms of stomach cancer, patients with gastric ulcers or middle-aged and older patients with newly occurring dyspeptic symptoms must confirm that it is not a malignant disease before administration. During the treatment with this medicine, rare cases of skin rash, hives, difficulty breathing, blood abnormalities, liver function abnormalities, digestive issues, neurological symptoms, etc. may occur, so if any abnormal symptoms arise, notify healthcare professionals immediately. Long-term use should be avoided, and regular blood tests along with liver and kidney function tests are recommended during treatment. If dizziness or drowsiness occurs, it is advisable to avoid driving or operating dangerous machinery, and since drug interactions may occur, inform your doctor of any medications you are taking. It is safe to avoid using this medicine during pregnancy or breastfeeding, and it is not recommended for children as safety and efficacy have not been established. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, so caution is needed. This medicine reduces gastric acid secretion and may promote bacterial growth in the gastrointestinal tract, so periodic check-ups, including eye examinations, may be required with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 56 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • myotonia
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • glossitis
  • skin itching
  • mild erythema multiforme
  • alopecia
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to protect it from air and moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for an extended period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.